Question 1

What are the potential benefits of participating in this trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Pharmacokinetics of Somatropin in Patients With End Stage Renal Disease Receiving Chronic Haemodialysis clinical trial (NCT01502137). Contact the study team or your healthcare provider for specific answers.

Question 2

How will my health be monitored during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Pharmacokinetics of Somatropin in Patients With End Stage Renal Disease Receiving Chronic Haemodialysis clinical trial (NCT01502137). Contact the study team or your healthcare provider for specific answers.

Question 3

What side effects should I expect from the growth hormone treatment?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Pharmacokinetics of Somatropin in Patients With End Stage Renal Disease Receiving Chronic Haemodialysis clinical trial (NCT01502137). Contact the study team or your healthcare provider for specific answers.

Question 4

How does this treatment compare to my current options?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Pharmacokinetics of Somatropin in Patients With End Stage Renal Disease Receiving Chronic Haemodialysis clinical trial (NCT01502137). Contact the study team or your healthcare provider for specific answers.

Question 5

What happens if I experience any adverse effects during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Pharmacokinetics of Somatropin in Patients With End Stage Renal Disease Receiving Chronic Haemodialysis clinical trial (NCT01502137). Contact the study team or your healthcare provider for specific answers.

What this study is about